PPARA and glioma: Based on these findings, considerable interest has been shown in PPAR ligands as potential therapeutic agents in the treatment of gliomas; however, the molecular mechanisms underlying the suppression of carcinogenesis in gliomas, determined by PPAR activation have not yet been fully elucidated.